Lymphoma Cancer Antibodies

Over the years, several treatments have been administered to patients with lymphoma cancer. Most have been successful but the success rate has not been as high as desired. Thus, even though treatments such as chemotherapy and radiotherapy have been used to cure lymphoma, the search for a more effective treatment method has been on-going. These researches have resulted in what is known as Monoclonal antibodies in lymphoma cancer. Lymphoma cancer antibodies are a non-conventional way of treating lymphoma in patients.

What are Lymphoma Cancer Antibodies?

This is the use of a type of immunotherapy in treating lymphoma and is called Monoclonal Antibody (mAB) Therapy.  Unlike chemotherapy which usually destroys some good cells in the body along with the cancer cells, Monoclonal Antibody Therapy makes use of specific antibodies in fighting the cancer cells; these antibodies are used to remove the cells from the body.  It is a therapy that depends on the body's immune system to fight the cancer.

Monoclonal antibodies come in varying types and they are each designed to find a single substance.  They can be used alone or with other forms of cancer treatment however that depends on the type and stage of the cancer.  The chief advantage of this form of lymphoma cancer treatment is that it does not attack other good cells in the body.  Since these lymphoma cancer antibodies are designed to target and work on a single type of cell, they focus only on the cancer cells and leave the other cells in the body alone.  Because they rely on the body's immune system, they are called immunotherapy.

How are Lymphoma Cancer Antibodies Performed?

Monoclonal Antibodies are generally referred to as targeted therapies and they are used for treating cancers like leukaemia and lymphoma.  These are artificial antibodies which are made to work with the body's immune system.

There are two types of monoclonal antibodies and these are Naked or Unconjugated monoclonal antibodies and conjugated monoclonal antibodies.  The naked or unconjugated monoclonal antibodies are used as a single therapy and are not combined with either drugs or radiotherapy.  How they function is to attach themselves to the antigens on the cancer cell at which point the body's immune system receives the message to destroy them.  This is commonly used in treating lymphoma.  Conjugated monoclonal antibodies on the other hand are used with other forms of cancer therapy and in fact act as a carrier to deliver the drugs, radioactive isotopes or any other form of treatment, directly to the cancer cells.

Where Can I Get Lymphoma Cancer Antibodies?

As this is a new branch of cancer treatment, lymphoma cancer antibodies treatment is not found in very many hospitals however, there are a few that make provision for it including:

  • Newcastle Hospitals
  • Christie Hospital NHS Foundation Trust Hospital in Manchester, Barts
  • The London NHS trust, and The Royal Liverpool University Hospital

The use of lymphoma cancer antibodies in lymphoma treatment is still very much in its research stages although a number of hospitals and cancer centres have begun making use of it.  Where it is available, it is a highly effective method of curing lymphoma without the attendant side effects associated with chemotherapy and radiotherapy.

To Top